Khalid Muhammad
Impact in
- Drug Discovery top 2%
- Immunology top 5%
- T-cell and B-cell Immunology
- Psoriasis: Treatment and Pathogenesis
Papers in
- Immunology 13
- T-cell and B-cell Immunology 7
-
- Contact Dermatitis and Allergies 4
- Dermatology and Skin Diseases 3
- Co-authors
- Yasir Waheed (31 shared papers)Shiza Malik (10 shared papers)Edgar Serfling (17 shared papers)Andreas Kerstan (8 shared papers)Matthias Goebeler (7 shared papers)Petra Roll (8 shared papers)Thomas Dörner (7 shared papers)Helal F. Hetta (11 shared papers)
- Journals
- Vaccines (10 papers)Frontiers in Immunology (6 papers)Molecules (5 papers)Nature Communications (4 papers)International Journal of Molecular Sciences (3 papers)
- Partner nations
- United Arab EmiratesPakistanGermany
In The Last Decade
Khalid Muhammad
73 papers receiving 3.4k citations
Khalid Muhammad's Hit Papers
Peers
Comparison fields: 5 of 152
- Drug Discovery 19
- Immunology 490
- Biomaterials 234
- Health Informatics 41
- Oncology 334
Countries citing papers authored by Khalid Muhammad
This map shows the geographic impact of Khalid Muhammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Muhammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Muhammad more than expected).
Fields of papers citing papers by Khalid Muhammad
This network shows the impact of papers produced by Khalid Muhammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Muhammad. The network helps show where Khalid Muhammad may publish in the future.
Co-authors
The 25 scholars most cited alongside Khalid Muhammad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nanotechnology: A Revolution in Modern Industry Hit paper breakdown → | 2023 | 717 |
| 2 | Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer Hit paper breakdown → | 2021 | 604 |
| 3 | Emerging Applications of Nanotechnology in Healthcare and Medicine Hit paper breakdown → | 2023 | 349 |
| 4 | 2017 | 167 | |
| 5 | Current Developments in the Immunology of Psoriasis. | 2020 | 163 |
| 6 | 2011 | 84 | |
| 7 | 2013 | 83 | |
| 8 | 2021 | 79 | |
| 9 | 2020 | 64 | |
| 10 | 2021 | 64 | |
| 11 | 2016 | 60 | |
| 12 | 2023 | 52 | |
| 13 | 2015 | 51 | |
| 14 | 2024 | 48 | |
| 15 | 2025 | 44 | |
| 16 | 2021 | 42 | |
| 17 | 2013 | 38 | |
| 18 | 2011 | 36 | |
| 19 | 2009 | 35 | |
| 20 | 2020 | 34 |
About Khalid Muhammad
Khalid Muhammad is a scholar working on Immunology, Dermatology, Rheumatology, Molecular Biology and Infectious Diseases, having authored 74 papers that have together received 3.5k indexed citations. Recurring topics across this work include Signaling Pathways in Disease (11 papers), Rheumatoid Arthritis Research and Therapies (8 papers), T-cell and B-cell Immunology (7 papers), vaccines and immunoinformatics approaches (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Contact Dermatitis and Allergies (4 papers), Gut microbiota and health (4 papers) and Dermatology and Skin Diseases (3 papers). The work is most often cited by research in Drug Discovery (19 citations), Immunology (490 citations), Biomaterials (234 citations), Health Informatics (41 citations) and Oncology (334 citations). Khalid Muhammad has collaborated with scholars based in United Arab Emirates, Pakistan and Germany. Frequent co-authors include Yasir Waheed, Shiza Malik, Edgar Serfling, Andreas Kerstan, Matthias Goebeler, Petra Roll, Thomas Dörner, Helal F. Hetta, Hans‐Peter Tony and Hermann Einsele. Their work appears in journals such as Vaccines, Frontiers in Immunology, Molecules, Nature Communications and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.